Introduction {#s1}
============

Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality ([@GAN060C28]). Despite the several strategies for treatment, the frequency of PTB has not changed significantly during the past three decades and the mechanisms underlying the initiation of both preterm and term labor remain largely unknown ([@GAN060C3]; [@GAN060C8]; [@GAN060C12]). Uterine contractions must be coordinated with a softening of the cervix for a successful delivery. Cervical softening involves intensive remodeling of the extracellular matrix (ECM), with extensive changes in concentration and composition of collagens ([@GAN060C39]; [@GAN060C5]) and proteoglycans ([@GAN060C24]; [@GAN060C43]). Cytokines and several other mediators, including estrogen, progesterone, prostaglandins and nitric oxide, participate in the remodeling of ECM and ripening of the human cervix ([@GAN060C33]; [@GAN060C1]; [@GAN060C8]; [@GAN060C37]). This process can be regarded as an inflammatory reaction associated with elevated levels of cytokines at the time of both preterm and time labor ([@GAN060C31]; [@GAN060C36]). Interleukin (IL)-6 and IL-8 increase at least 100-fold at term labor ([@GAN060C31]). IL-8 promotes recruitment and activation of neutrophils, which in turn secrete proteolytic enzymes, such as matrix metalloproteinase (MMP)-8 and MMP-9 ([@GAN060C26]; [@GAN060C34]). The MMPs play a central role in the degradation of ECM components. The levels of MMPs in the cervix, lower uterine segment, amniotic fluid, fetal membranes and maternal plasma increase at labor time ([@GAN060C38]; [@GAN060C44]; [@GAN060C34]; [@GAN060C32]; [@GAN060C42]). Polymorphism in MMP-1 and MMP-9 genes has been shown to be associated with preterm premature rupture of membranes ([@GAN060C6]; [@GAN060C7]).

Corticotropin-releasing hormone (CRH) is the principal regulator of the hypothalamic--pituitary--adrenal (HPA) axis. The HPA axis has been of interest in connection with labor since Liggins induced premature parturition in sheep with corticotropin and cortisol infusion ([@GAN060C20]). CRH is produced by fetomaternal tissues and secreted into the maternal circulation, so that during pregnancy the maternal plasma levels of this hormone increase, while the corresponding binding protein (CRH-BP) levels are reduced ([@GAN060C21]; [@GAN060C9]). Patients at risk for PTB have significantly elevated plasma levels of CRH and lower CRH-BP levels ([@GAN060C10]).

CRH, CRH-BP and the receptors for CRH, CRH-R1 and CRH-R2 are expressed in human placenta, deciduas, fetal membranes, endometrium and myometrium ([@GAN060C16]). Furthermore, CRH increases MMP-9 protein secretion by cultured cells from placenta and fetal membranes ([@GAN060C19]). In our previous study we have localized CRH, CRH-BP, CRH-R1 and CRH-R2 in the cervix, which suggested that the cervix may be a target for CRH action ([@GAN060C17]). Therefore, our present aim was to determine if CRH has an effect on the secretion of IL-8, MMP-1 and MMP-3 in both preterm and term cervical fibroblasts. Furthermore, our aim was to compare the levels of mRNA and protein expression of MMP-1, MMP-3, MMP-8 and MMP-9 in human cervical tissue in preterm and term labor as well as not in labor.

Materials and Methods {#s2}
=====================

Patients {#s2a}
--------

A total of 51 women were included in the study for the analysis of MMP expression. Two preterm groups consisted of 14 women undergoing preterm labor (PTL) and 7 women delivered preterm by Caesarean section prior to the onset of labor (PTnotL). Preterm delivery was defined as delivery before the 37th week of gestation. Two control term groups included 13 women undergoing normal term labor (TL) and 17 women at term not in labor delivered by elective Caesarean section (TnotL). The labor groups (PTL and TL) were in active labor and demonstrated a ripe cervix, with dilatation more than 4 cm. They were either delivered vaginally or by emergency Caesarean section due to malpresentation (at preterm and at term) or due to threatening fetal asphyxia (at term). In all patients delivered by Caesarean section, the assessment of cervical dilatation was established immediately before surgery. Women not in labor (PTnotL and TnotL) had unripe cervices (with a Bishop score of \<5 points) and were delivered by Caesarean section prior to the onset of labor. The preterm indications were suspected placental abruption or intrauterine growth retardation and the term indications were breech presentation, humanitarian or disproportion.

Cervical biopsies from an additional nine women (four PTL and five TL) were used for the cultures of cervical fibroblasts.

None of the women included in the study suffered from pre-eclampsia, diabetes or other systemic disease, nor did any of our subjects demonstrate clinical signs of infection in connection with parturition or during the post-partal period.

There were no significant differences between these groups of women with respect to maternal age, parity, previous PTBs and Caesarean sections. Moreover, there was no significant difference in gestational age between the groups PTL and PTnotL or TL and TnotL. Clinical data on the women is presented in Table [I](#GAN060TB1){ref-type="table"}.

###### 

Clinical data on women included in the study.

  Parameter                                  mRNA and protein analysis in the cervical tissue   Cervical fibroblasts                                                      
  ------------------------------------------ -------------------------------------------------- ---------------------- ---------------- ---------------- ---------------- ----------------
  *n*                                        14                                                 13                     7                17               4                5
  Age                                        28 (18--37)                                        28 (20--36)            32 (27--35)      30 (25--39)      31 (30--36)      29 (23--31)
  Parity                                     1 (0--3)                                           1 (0--2)               1 (0--2)         0 (0--3)         0 (0--1)         1 (0--2)
  Previous preterm births in the group       1                                                  0                      1                2                0                0
  Previous Caesarian section                 0 (0--1)                                           0 (0--1)               0 (0--0)         0 (0--2)         0                0
  Previous Caesarian sections in the group   3                                                  2                      0                4                0                0
  Gestational age in fgw^a^                  33 (26--36)                                        40 (37--42)            27 (26--36)      38 (37--39)      30 (25--35)      40 (38--40)
  Gestational age in days                    238 (184--255)                                     283 (259--294)         193 (183--256)   270 (260--278)   214 (176--247)   280 (272--282)
  Treatment with corticosteroids             4                                                  0                      4                0                2                0

Data are presented as median (range) if not otherwise stated. ^a^full gestational weeks.

Prior to the performance of this study, the approval of the local Ethics Committee of Karolinska Institute (Ref. no. 97-089 and 04-637/4) and the informed consent of each subject was received.

Sampling procedure {#s2b}
------------------

Immediately following vaginal delivery and Caesarean section, a biopsy was taken transvaginally (at the 12 o\'clock position) from the anterior cervical lip with scissors and tweezers. The samples to be utilized for mRNA or protein analysis were immediately frozen and stored thereafter at −70°C. The biopsies to be used for the cultures of cervical fibroblasts were immersed in GIBCO™ RPMI 1640 Medium (Invitrogen Corporation, Paisly, Scotland, UK) and stored in refrigerator for a maximum of 24 h before proceeding to the establishment of cell cultures.

The limited amount of tissue available from each woman did not allow performance of all of the different analyses on each individual sample.

Tissue homogenization and extraction of RNA {#s2c}
-------------------------------------------

Tissue homogenization was carried out by the help of a dismembranation apparatus (Retsch KG, Haan, Germany) and followed by either RNA or protein extraction.

Total RNA was extracted using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) as described previously ([@GAN060C36]).

Treatment with DNase and reverse transcription {#s2d}
----------------------------------------------

The concentration of total RNA obtained was determined on the basis of the OD~260~ using a DU64^®^ spectrophotometer (Beckman, Palo Alto, CA, USA) and only samples exhibiting an OD~260~/OD~280~ ratio higher than 1.5 were used for RT--PCR. 2 µg total RNA, pre-treated with 2 µl RQ1 RNase-Free DNase (Promega, Madison, WI, USA), was used for RT reaction, which was performed using SuperScript™ RNase H^−^ Reverse Transcriptase (Invitrogen) as described elsewhere ([@GAN060C36]). The cDNA was stored at −70°C prior to use.

Real-time RT--PCR {#s2e}
-----------------

The levels of mRNA encoding MMP-1, MMP-3, MMP-8 and MMP-9 were quantified by real-time RT--PCR employing the Applied Biosystems 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). All determinations were performed in triplicate in Taqman Universal PCR Master Mix (Applied Biosystems) on 96-well optical PCR plates. Appropriate primers and probes were purchased from commercially available Taqman^®^ gene expression assays (Applied Biosystems). Two different Taqman^®^ gene expression assays were used for mRNA detection of MMP-8. Primers and probes in these two assays detect different sequences. The second assay was used to confirm unexpected results from the first assay. Assay IDs and GenBank accession numbers are presented in Table [II](#GAN060TB2){ref-type="table"}. For each reaction, 5 µl diluted cDNA (corresponding to 20 ng total RNA), 12.5 µl Universal Master Mix, 1.25 µl assay mixture and 18.75 µl sterile water was used. Real-time PCR reaction was carried out according to a standard manufacturer protocol involving 40--45 cycles of denaturation--annealing. The threshold cycles (C~T~), at which an increase in reporter fluorescence above the baseline signal could first be detected, were determined. 18s and β-actin were used as endogenous controls. The geometric mean of two endogenous controls was used for normalization of the mRNA levels for the gene of interest ([@GAN060C40]). The geometric mean was subtracted from the respective gene, giving the ΔC~T~ as a reflection of the relative mRNA expression. Since a higher ΔC~T~ corresponds to a lower mRNA expression, the ΔC~T~ values are presented inverted as 100/ΔC~T~. Serial dilutions of placental cDNA made from purchased total RNA (Ambion, Austin, TX, USA) were used for validation of the experiment.

###### 

Assay IDs and GenBank accession number for gene expression assays used for real-time RT--PCR.

  Gene         Assay ID        GenBank accession number
  ------------ --------------- --------------------------
  MMP-1        Hs00233958_m1   NM_002421.2
  MMP-3        Hs00233962_m1   NM_002422.3
  MMP-8^a^     Hs01029057_m1   NM_002424.1
  MMP-8^a^     Hs00233972_m1   NM_002424.1
  MMP-9        Hs00234579_m1   NM_004994.2
  18s^b^       4319413E        X03205.1
  β-actin^b^   4352935E        NM_001101.2

^a^Two different expression assays were used for mRNA detection of MMP-8; ^b^18s and β-actin were used as endogenous controls.

Protein extraction {#s2f}
------------------

Following the tissue homogenization, 1 ml of phosphate-buffered saline (PBS), including 0.01% Triton X-100, was added. After centrifugation at 10 000*g*, 4°C for 10 min, supernatant was retrieved and stored in aliquots at −70°C until analyzed.

Total protein concentration was determined using a BCA protein assay kit (Pierce Chemical Co., Rockford, IL, USA) according to the manufacturer\'s instructions.

Determination of the protein levels of MMPs {#s2g}
-------------------------------------------

The concentrations of all MMPs in the supernatants were determined employing Amersham Matrix metalloproteinase Biotrak ELISA system (GE Healthcare, Amersham Place, Buckinghamshire, UK) according to the manufacturer\'s instructions. The assays detect the levels of total MMP-1, -3, -8 and -9. The results were interpolated from the standard reference curve provided with each kit. The sensitivity of kits was 1.7 ng/ml for MMP-1, 2.35 ng/ml for MMP-3, 0.032 ng/ml for MMP-8 and 0.6 ng/ml for MMP-9. The concentrations of MMP-1, -3, -8 and -9 were normalized against the total protein concentration.

Cell culture establishment {#s2h}
--------------------------

Cervical fibroblasts were established from the cervical biopsies obtained directly after vaginal delivery. The biopsies were rinsed in Earle\'s Minimal Essential Medium (EMEM), cut into pieces of ∼1 mm^3^, and allowed to adhere to the bottom of the culture chamber at 37°C and 5% CO~2~, for 4 h before addition of EMEM with penicillin (1%), streptomycin (1%), glutamine (1%) and donor calf serum (10%). Explants were incubated for 2--3 weeks until confluent fibroblast cultures were obtained. Sub-cultures of cells were done by trypsinization according to standard procedures giving rise to two separate but identical preparations for further experiments. All experiments were done with cells in passages between 3 and 5.

Phenotype of the fibroblasts was identified morphologically and employing three fibroblast markers: vimentin (sc53464, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-fibroblast surface protein antibody 1B10 (F4771, Sigma, St Louis, Missouri, USA) and prolyl-4-hydroxylase beta (AF0910-1, Acris Antibodies GmbH, Hiddenhausen, Germany). The cells were fixed with 4% formaldehyde for 10 min, permeabilized with 0.2% Triton X-100 in PBS for 10 min, and unspecific binding was blocked with a 2% solution of bovine serum albumin in PBS for 1 h. The cells were then incubated with the primary antibodies (1:100 in blocking buffer) overnight at 4°C. Alexa Fluor 488-conjugated or Alexa Flour 594-conjugated antibodies, raised in goat and directed against immunoglobulins of the species used to raise the primary antibody, were used for detection of the bound primary antibodies (1:200, 1 h). Between each step the cells were carefully rinsed with PBS. A light-scanning microscope was used to examine the cells.

Stimulation experiments {#s2i}
-----------------------

Cervical fibroblasts were seeded on 12-well cell culture plates and grown until confluence, usually after 3 days. Cells were stimulated for 18 h with CRH (Sigma) at concentrations ranging between 10^−6^ and 10^−13^ M and non-stimulated control cells were cultured in parallel. All concentrations were performed in duplicate. Media samples were collected and frozen until analysis. MMP-1, MMP-3 and MMP-9 were quantified using ELISA as described earlier. Quantification of IL-8 was performed employing IMMULITE Automated Analyser (Diagnostic Products Corp., Los Angeles, CA, USA), using the commercially available immulite chemiluminescent enzyme immunometric assay (Immulite^®^, Diagnostic Products Corp.) according to the manufacturer\'s instructions. The sensitivity of the assay was 2 pg/ml. The measured MMP-1, MMP-3 and IL-8 concentrations were normalized to the total amount of protein in corresponding cell layer, as determined using a BCA protein assay kit (Pierce Chemical Co.).

Statistical analysis {#s2j}
--------------------

Comparisons between two independent groups were performed utilizing the Mann--Whitney *U*-test. When more than two groups were compared, the Kruskal--Wallis test was applied, followed by multiple comparison with Bonferroni--Dunn correction. For the comparison of the results in the stimulation experiments, the Friedman ANOVA and Kendall\'s concordance and the Wilcoxon matched pair test were employed. In all cases, a *P*-value of \<0.05 was considered to be statistically significant. All calculations were performed with the STATISTICA 8.0 software (StatSoft Inc, Tulsa, OK, USA).

Results {#s3}
=======

The mRNA expression of MMP-1, -3, -8 and -9 in the cervical tissue {#s3a}
------------------------------------------------------------------

The mRNA expression of MMP-1, MMP-3 and MMP-9 was significantly higher in the term labor compared with term not in labor group (Fig. [1](#GAN060F1){ref-type="fig"}A, B and D). The preterm labor group showed a similar pattern and this difference reached statistical significance for MMP-3 and MMP-9. There were no significant differences between the preterm and respective term control groups. There were no differences between the groups in MMP-8 mRNA expression and the results were the same with two different Taqman^®^ gene expression assays (Fig. [1](#GAN060F1){ref-type="fig"}C).

![The mRNA expression of MMP-1 (**A**), MMP-3 (**B**), MMP-8 (**C**) and MMP-9 (**D**) in the cervical tissue.\
C~T~, the threshold cycle at which an increase in reporter fluorescence above the baseline signal is first detected. The mRNA levels are normalized using geometric mean (GM) of two endogenous controls (18s and β-actin). The studied groups are: preterm labor (PTL), preterm not in labor (PTnotL), term labor (TL), term not in labor (TnotL). The box represents median value with 25--75% of all data falling within the box. The whiskers extend to the non-outlier range. The outliers are marked as circles. The number of samples analyzed in each group is shown under the group name. Statistically significant differences are indicated above the plots.](gan06001){#GAN060F1}

Protein levels of MMPs in the cervical tissue {#s3b}
---------------------------------------------

MMP-8 and MMP-9 were detected in all the samples. The laboring groups had higher concentrations of MMP-8 and MMP-9, where the difference was statistically significant between the term in labor and not in labor groups (Fig. [2](#GAN060F2){ref-type="fig"}). There were no significant differences between the preterm and respective term control groups.

![Protein levels of MMP-8 (**A**) and MMP-9 (**B**) in the cervical tissue.\
The protein levels are normalized to the total amount of protein. The studied groups are: preterm labor (PTL), preterm not in labor (PTnotL), term labor (TL), term not in labor (TnotL). The box represents median value with 25--75% of all data falling within the box. The whiskers extend to the non-outlier range. The outliers are marked as circles. The number of samples analyzed in each group is shown under the group name. Statistically significant differences are indicated above the plots.](gan06002){#GAN060F2}

The concentrations of MMP-1 and MMP-3 were generally low in all the samples. MMP-1 was below detection limit in 25 samples and MMP-3 was undetected in 9 samples. There were no significant differences in MMP-1 and MMP-3 concentrations between the groups (data not shown).

Stimulation of cervical fibroblasts {#s3c}
-----------------------------------

Cell cultures from preterm and term cervical biopsies stained positively for all three fibroblast markers (Fig. [3](#GAN060F3){ref-type="fig"}).

![Immunostaining of cell cultures for fibroblast markers.\
Cell cultures from preterm (left column) and term (right column) cervical biopsies were immunostained using antibodies directed against vimentin (**A** and **B**), fibroblast surface marker 1B10 (**C** and **D**) and prolyl-4-hydroxylase beta (**E** and **F**).](gan06003){#GAN060F3}

IL-8, MMP-1 and MMP-3 were detected in all culture medium samples of cervical fibroblasts. MMP-9 was not detected in any of the samples.

CRH significantly increased the secretion of IL-8 from the term and preterm cervical fibroblasts at concentrations 10^−7^--10^−6^ and 10^−8^, 10^−6^ M, respectively, compared with controls (Fig. [4](#GAN060F4){ref-type="fig"}A). The levels of MMP-1 and MMP-3 were not significantly changed by CRH (Fig. [4](#GAN060F4){ref-type="fig"}B and C).

![The effect of CRH on secretion of IL-8 (**A**), MMP-1 (**B**) and MMP-3 (**C**) by preterm (PTL) and term (TL) cervical fibroblasts.\
The cervical fibroblasts were incubated with different CRH concentrations for 18h and the levels of IL-8, MMP-1 and MMP-3 determined in the culture medium. The protein levels are normalized to the total amount of protein in the corresponding cell layer. Different concentrations (M) of CRH are indicated on the x-axis. Data is presented as mean ± SD. \**P* \< 0.05 (compared with control). The secretion of IL-8 and MMP-1 was higher in preterm cervical fibroblasts (*P* \< 0.001 and *P* \< 0.05, respectively). MMP-3 secretion was higher in term cervical fibroblasts (*P* \< 0.001).](gan06004){#GAN060F4}

Furthermore, preterm and term cervical fibroblasts showed different secretion patterns of IL-8, MMP-1 and MMP-3. This difference was statistically significant when the whole preterm group was compared with the term group. The secretion of IL-8 and MMP-1 was higher in the preterm cervical fibroblasts (*P* \< 0.001 and \<0.05, respectively). However, MMP-3 secretion was higher in the term cervical fibroblasts (*P* \< 0.001) (Fig. [4](#GAN060F4){ref-type="fig"}A--C).

Discussion {#s4}
==========

In the present study, we have demonstrated for the first time, that the mRNA and protein expression of several MMPs increase in cervix both at preterm and term labor. This finding together with our earlier studies on CRH and cytokines in preterm cervix ([@GAN060C37]; [@GAN060C17]) indicates that preterm cervical ripening is the same inflammatory process as the cervical ripening at term.

In this study, we also analyzed the effect of CRH on the secretion of MMPs and IL-8 in the cervical fibroblasts. To our knowledge, this is the first such kind of study on the preterm and term cervical fibroblasts. We have shown that CRH increased the secretion of IL-8 in both preterm and term cervical fibroblasts, but did not affect the secretion of MMP-1 and MMP-3. MMP-9 was not detected in the culture medium, which confirms the earlier studies that MMP-9 is not produced by cervical fibroblasts ([@GAN060C18]; [@GAN060C34]). IL-8 is an important mediator of cervical ripening ([@GAN060C26]; [@GAN060C30]). The fact that CRH and its receptors are localized in the cervix ([@GAN060C17]) and that it has an effect on IL-8 secretion from cervical fibroblasts points towards the possible role of CRH in the process of the cervical ripening. Several studies have shown that CRH can stimulate the production of proinflammatory cytokines in different cells ([@GAN060C2]; [@GAN060C45]; [@GAN060C41]), although some studies present contradicting results ([@GAN060C2]; [@GAN060C29]). The possible mechanism by which CRH induces IL-8 production in the cervical fibroblasts could be a selective activation of the p38/MAPK signaling pathway ([@GAN060C41]). However, CRH could be involved in several different signaling pathways, like reactive oxygen intermediates ([@GAN060C45]) or the NF-κB signaling pathway ([@GAN060C47]; [@GAN060C46]).

The results on the secretion of MMP-1 and MMP-3 from cervical fibroblasts contradict the findings by [@GAN060C19]). Li and Challis showed an induced secretion of MMP-9 by CRH in the cell cultures from human placenta and fetal membranes. The explanation for this contradiction could be that the cell cultures were established from different tissues. Furthermore, different MMPs were analyzed. However, cytokines are known to stimulate the production of MMPs ([@GAN060C15]; [@GAN060C13], [@GAN060C14]; [@GAN060C25]), so it would be logical to expect an elevation of MMP-1 and MMP-3 levels when there is an increased secretion of IL-8. One possible explanation could be that even if the levels of IL-8 increase under the action of CRH, the concentration might still be too low to induce secretion of MMPs. Another explanation may be that IL-8 can induce the activity of MMPs ([@GAN060C35]) with no effect on the total concentration of MMPs.

One interesting finding of this study is that preterm and term cervical fibroblasts show different secretion patterns of IL-8, MMP-1 and MMP-3, where IL-8 and MMP-1 are secreted at higher levels in preterm and MMP-3 in term cervical fibroblasts. In our unpublished study, we were able to show the differences in proteoglycan production in preterm and term cervical fibroblasts. These findings indicate that cervical fibroblasts at preterm and term vaginal delivery may have different phenotypes. However, in our studies, we were not able to show any differences in the concentrations of cytokines or MMPs in the preterm cervical tissue compared with term. One explanation for this could be that we have many different cells producing MMPs and IL-8 in the cervical tissue, like leukocytes, cervical smooth muscle cells and macrophages. The clinical significance of different secretion patterns of IL-8, MMP-1 and MMP3 in preterm and term cervical fibroblasts still needs to be elucidated.

A notable observation is that MMP-1 was higher in preterm cervical fibroblasts, whereas MMP-3 was higher at term. MMP-1 and MMP-3 have different substrates in the tissue: MMP-1 breaks down fibrillar and non-fibrillar collagens, whereas MMP-3 cleaves proteoglycans, fibronectine, gelatins, collagen IV and V ([@GAN060C11]). Earlier studies have shown some differences between MMP-1 and MMP-3 in amniotic fluid. MMP-1, but not MMP-3, concentrations increase in amniotic fluid with advancing gestational age. Spontaneous parturition at term and preterm is associated with significant increase in amniotic fluid concentrations of MMP-3, but not MMP-1 ([@GAN060C23]; [@GAN060C27]).

The main strength of this study is that human material was used. We have well-defined patient groups both in labor and not in labor at preterm and at term. Cervical biopsies are extremely hard to obtain especially in relation to preterm delivery, which is the reason why so few studies are conducted on the human preterm cervix. Our group has applied this sampling procedure for almost 30 years to obtain cervical tissue samples including squamous and cylindrical epithelium, vessels, glands and ECM. The study also includes both analysis in the cervical tissue and experiments on the cervical fibroblasts *in vitro*.

A weakness of the study could be the relatively small size of the groups investigated. This could be explained by the invasive sampling procedure, which is extremely hard to coordinate with delivery and renders it difficult to get a large number of samples. Nevertheless, important differences between the groups are still possible to detect as we have seen in our earlier studies ([@GAN060C30], [@GAN060C32]). Secondly, the use of different passages of cervical fibroblasts could be seen as disadvantage. However, we have seen a stable phenotype until passage 8 in our earlier studies of cervical fibroblasts ([@GAN060C22]). In this study, we have determined the levels of total MMPs. It is possible that the results could have been different if we had examined the active forms of MMPs. Prostaglandin E~2~, for instance, induces activation of MMP-3, but does not affect MMP-3 total protein in the rat cervix ([@GAN060C4]). However, proteolytic activity of MMP-1 and MMP-3 follows the same pattern as total protein levels in human decidual cells ([@GAN060C25]). We have chosen to perform analysis of the total MMPs, as it was not possible to perform analysis of both total and active forms in this study because of the shortage of material. Moreover, the lower levels of active MMPs could be undetectable ([@GAN060C19]).

In conclusion, the current study shows that spontaneous parturition at preterm and at term is associated with elevated mRNA and protein levels of MMPs in the cervical tissue. However, different secretion patterns of IL-8, MMP-1 and MMP-3 in preterm and term cervical fibroblasts indicate that they might have different phenotypes. Furthermore, CRH stimulates the secretion of IL-8 both in preterm and term cervical fibroblasts, which suggests that CRH could be involved in the process of cervical ripening. Further studies are still needed to elucidate the significance of these findings.
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